PeptidesRx Review

Site is closed and under construction
7.3
★★★★☆3.7/5

PeptidesRx scores highest on the strength of its clinical program — drug options and dosing support.

Semaglutide

$169/mo

Tirzepatide

$309/mo

PeptidesRx: Site is closed and under construction. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.

See our top-rated GLP-1 providers →
Compare top-rated alternatives ↓

PeptidesRx is a Fort Worth, TX-based licensed telehealth platform offering physician-supervised compounded semaglutide, tirzepatide, and a broader prescription peptide menu. Board-certified medical director, licensed nurse practitioners conducting good-faith examinations, transparent pricing, and shipped directly to patients nationwide. Positions itself as a compliance-focused alternative to gray-market peptide vendors.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideCompliance focusedPhysician supervisedTransparent pricing

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to PeptidesRx

7.2/ 10
Verified partner

Fella Health

Best for: men's weight loss

★★★★☆3.6/5

Editorial score · methodology

$165/mosemaglutide
$399/motirzepatide
CompoundedSemaglutideTirzepatideBoard-Certified Clinicians
Get StartedRead full Fella Health review →
7.6/ 10
Verified partner

SkinnyRx

Best for: mainstream telehealth GLP-1 access

★★★★☆3.8/5

Editorial score · methodology

$149/mosemaglutide
$224/motirzepatide
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full SkinnyRx review →
7.8/ 10
Verified partner

Embody

Best for: low flat-rate compounded GLP-1 pricing at every dose

★★★★☆3.9/5

Editorial score · methodology

$79/mosemaglutide
$129/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →
PeptidesRx
3.7 / 5
Our editorial rating

PeptidesRx at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$169/mo
What's included
Consult
FDA status
No FDA warning letter on record

How we scored PeptidesRx

Each dimension is scored algorithmically from PeptidesRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

7.5/10

At $169/mo, PeptidesRx runs in line with the $169 median for GLP-1 providers.

Effectiveness25%

8.1/10

PeptidesRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.4/10

Online intake and platform experience — consult included in the price; 6 platform features disclosed.

Trust & Safety15%

7.3/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.1/10

PeptidesRx's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

5.9/10

PeptidesRx provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
637providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this PeptidesRx review

Last checked August 2026
  • Confirmed current pricing across 3 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$169–$309/mo across 3 dose/plan tiers — checked August 2026
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with PeptidesRx

We walked PeptidesRx’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Browse the catalog and select semaglutide or tirzepatide (Weight Loss / GLP-1 Therapy).
  2. 2Complete a health intake form.
  3. 3Have a telehealth consultation with a licensed PeptidesRx provider (before any prescription is issued).
  4. 4The medical team reviews; the prescription is sent to a compounding pharmacy that ships to you.
  5. 5Results are monitored with protocol adjustments.
Price shown before you start
  • Compounded semaglutide tiers: Starter $249/mo, Full Protocol $399/mo, Elite $549/mo.
  • Compounded tirzepatide tiers: Starter $299/mo, Full Protocol $399/mo, Elite $549/mo.
  • Framed explicitly for weight loss; 'no in-office visit required.'
  • Homepage states a 'quick telehealth consultation' is required before a prescription (not specified as live video).
  • No lab-work requirement stated.

PeptidesRx customer support

GLP-1 medications PeptidesRx offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Peptides PeptidesRx offers

Beyond GLP-1s, PeptidesRx also offers these peptides — tap any for our evidence-based guide.

Pricing

Prices re-verified

0.25mgCompounded
$169/mo
semaglutide
1mgCompounded
$239/mo
semaglutide
2.5mgCompounded
$309/mo
tirzepatide

Ready to get started?

Plans and promotions change often — check PeptidesRx's current pricing and active discounts before you decide.

What we like

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Watch-outs

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

PeptidesRx: a compliance-first answer to the gray-market peptide problem

PeptidesRx (the storefront is GetPeptidesRx) is a Fort Worth, Texas telehealth platform built around a single argument: that compounded semaglutide, tirzepatide, and the wider world of prescription peptides should come through a licensed clinical channel, not a 'research chemicals — not for human use' loophole. That positioning is the whole reason to consider it. If you've been tempted by the cheap vials floating around peptide forums but don't want to gamble on an unregulated source, PeptidesRx is selling you the legitimate version of that experience: a real provider, a real prescription, shipped to your door. It is worth it for the buyer who specifically values that line in the sand, and skippable for someone who just wants the biggest, most established GLP-1 brand.

How the pricing actually works

PeptidesRx publishes a clear, product-by-product menu rather than bundling everything into one membership. Compounded semaglutide starts at $169 a month at the lowest starter dose, with the price stepping up as your dose climbs, and compounded tirzepatide sits a bit higher again. For context, that opening rate lands right around the category median of $169, so this is a mid-market price — not a loss-leader teaser and not a premium concierge fee.

A few things to understand before you read the number as your final bill:

  • The telehealth consultation is included — you don't pay a separate visit fee on top of the medication. PeptidesRx is explicit that no medication is prescribed or dispensed without a valid consult with a licensed provider first.
  • Pricing is dose-based, not flat. The starter dose is the cheapest entry point, and your monthly cost rises as you titrate up, which is normal for compounded GLP-1s but means the headline figure is the floor, not the ceiling.
  • The site runs a 'Protocol Cart' that totals your selected products into one monthly charge that renews automatically. It's a subscription, billed monthly, cancel-anytime — so treat it like an ongoing commitment you actively manage, not a one-time purchase.
  • Medication and shipping inclusion in the headline price isn't spelled out on the page, so confirm exactly what's bundled before your card is charged.

There's no first-month promo rate to chase here, which is honestly fine — a stable price you understand beats a discounted first month followed by a jump you didn't see coming.

The medications, and how they're dispensed

The two weight-focused options are compounded semaglutide (the molecule in Ozempic and Wegovy) and compounded tirzepatide (the molecule in Mounjaro and Zepbound), both given as weekly injections. These are compounded versions, not the brand-name pens, which is what keeps the price in this range. Around those two, PeptidesRx layers a broader prescription peptide menu — and that's the part to be clear-eyed about. The wide catalog is part of the brand's identity, but if your only goal is GLP-1 weight loss, the extra menu is noise you can ignore. Build a cart with just the GLP-1 you came for and leave the rest.

What genuinely sets it apart

The real differentiator isn't the drug list — almost everyone offers compounded semaglutide and tirzepatide now. It's the clinical packaging. PeptidesRx leads with a board-certified medical director and licensed nurse practitioners who conduct good-faith examinations before anything is prescribed, and it frames itself directly against gray-market peptide vendors. Plenty of sellers in this corner of the market route 'peptides' through a not-for-human-use channel to dodge the rules. A provider that insists on a licensed prescriber and a documented visit for every order is offering something concrete. You get a real prescription, with a clinician's name attached, instead of an anonymous vial.

Who should choose it

  • Buyers who specifically want the compliant, prescription-backed version of compounded peptides rather than an unregulated source.
  • People who like transparent, dose-by-dose pricing with the consult included and no surprise add-on fees.
  • Anyone curious about peptides beyond GLP-1s who still wants a licensed provider in the loop.

Who should skip it

  • Shoppers who want the biggest, most established name and the deepest support infrastructure — larger players like Henry Meds or Hims operate at a scale PeptidesRx doesn't match.
  • Anyone who wants brand-name Ozempic, Wegovy, Mounjaro, or Zepbound — this is a compounded-only menu.
  • People who'd find the sprawling peptide catalog more distracting than appealing and just want a focused GLP-1 program.

Trust, safety, and the open questions

On the encouraging side: there are no FDA warning letters on file for PeptidesRx, and the consult-required, licensed-prescriber model is exactly the kind of oversight that should exist in compounded peptides. The site states plainly that a telehealth consult with a licensed provider comes before any prescription, and that nothing is dispensed without it. The honest caveats start with geography. PeptidesRx does not publish a list of states it serves. It only says services are available 'where permitted by applicable law' and that its providers are licensed in the states they serve, so check that your state is covered before signing up. Catalog prices only appear once the cart builds them, so treat the menu figures as a guide until checkout. And it doesn't name an accredited compounding pharmacy partner anywhere public, so the specific pharmacy behind your medication is worth asking about. You can see how we weigh these factors in our scoring methodology.

Bottom line

PeptidesRx is a focused, mid-priced, compliance-forward way to get compounded semaglutide or tirzepatide from a licensed provider, with the consult baked into a transparent dose-based price starting around $169. Its strongest selling point is also its narrowest: it's the legitimate, prescription-backed alternative to buying peptides from the gray market. If that distinction matters to you, it's a credible pick — just confirm your state is served and ask which pharmacy fills your script before you commit. If you mostly want scale, brand-name options, or a heavily resourced support team, a larger platform will serve you better.

If you're weighing alternatives, Fella Health ($165/month) and Enhance MD ($169/month) are among the closest options we track to PeptidesRx.

The Bottom Line

PeptidesRx scores highest on the strength of its clinical program — drug options and dosing support.

Score: 7.3/10Best for: patients prioritizing regulatory compliance in the compounded spaceFrom: $169/mo

PeptidesRx might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider Fella Health.

Frequently Asked Questions

PeptidesRx is a Fort Worth, Texas-based telehealth platform that positions itself as a compliance-focused alternative to gray-market peptide vendors, with a board-certified medical director and licensed nurse practitioners who conduct a good-faith exam before anything is prescribed. It states that no medication is dispensed without a valid consultation with a licensed provider. It operates as a real telehealth service, but because it works in the compounded and prescription-peptide space, you should still check licensing and review any plan with your own licensed clinician.
Look for real clinical oversight: licensed prescribers, a required medical consultation before any product is dispensed, transparent pricing, and dispensing through licensed US pharmacies rather than 'research use only' or 'not for human consumption' labeling. PeptidesRx advertises these compliance features, which distinguishes it from gray-market research-chemical sellers. Be cautious of any vendor that ships injectable peptides without a prescription or clinical evaluation, and confirm details with a licensed clinician.
PeptidesRx offers compounded semaglutide and tirzepatide for weight management, alongside a broader prescription peptide menu that includes BPC-157, TB-500, PT-141, and NAD. Which, if any, of these is appropriate is a decision to make with a licensed prescriber based on your individual health, not a self-directed choice.
Starting prices run around $169 per month for compounded semaglutide, about $239 for a higher semaglutide dose, and roughly $309 for tirzepatide, and the company advertises transparent pricing with no surprise fees. Treat these figures as estimates, since the live catalog only loads once you are inside the shop. Confirm the current price at checkout before enrolling.
No. Its compounded semaglutide and tirzepatide are not FDA-approved as finished products, and research peptides such as BPC-157, TB-500, and PT-141 are not FDA-approved finished drugs either; several are largely unapproved and lack solid human trial data. Only certain active ingredients hold approval in specific approved products. This does not amount to an endorsement of unapproved peptide use, and you should only consider any of these under the guidance of a licensed clinician.
Because many peptides are not FDA-approved finished products, their long-term safety, correct dosing, purity, and effectiveness are often not well established in humans, and quality can vary between sources. Possible downsides include injection-site reactions, unknown or off-target effects, interactions with other medications, and limited regulatory oversight. Anyone considering peptides should do so only after a thorough evaluation with a licensed clinician who can weigh the potential risks against any benefit.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Smaller scale than Henry Meds or Hims; Wide peptide menu may distract from GLP-1 focus. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this PeptidesRx review:

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.